Log in

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) Earnings Date, Estimates & History

-0.03 (-30.00 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $0.07
50-Day Range
MA: $0.13
52-Week Range
Now: $0.07
Volume27.92 million shs
Average Volume32.91 million shs
Market Capitalization$39.48 million
P/E RatioN/A
Dividend YieldN/A


Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) Earnings Information

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) last posted its earnings results on August 10th, 2020. The reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) has generated ($0.19) earnings per share over the last year. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 10th, 2020 based off prior year's report dates.

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE ZOM) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/11/2020Q1 2020($0.02)($0.02)($0.02)N/A
5/10/2019Q1 2019($0.12)($0.12)N/A
2/26/2019Q4 2018($0.09)($0.09)N/A
11/13/2018Q3 2018($0.02)($0.02)N/A
8/9/2018Q2 2018($0.04)($0.04)N/A
5/15/2018Q1 2018($0.02)($0.02)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.